Keyword: Olivier Brandicourt
Sanofi is working on a succession plan for CEO Olivier Brandicourt, who'll hit mandatory retirement age in 2021.
Some Big Pharma CEOs got big pay raises last year despite problems at their companies. Sanofi chief Olivier Brandicourt wasn't one of them.
The move comes as Lilly and the other two big diabetes drugmakers face increasing political pressure on rising insulin prices.
Once the Senate finance committee’s drug pricing hearing started on Tuesday, it didn’t take long for sparks to fly.
After a strong fourth quarter, Sanofi expects further growth in 2019.
Dupixent grew sales by 28% sequentially at constant currencies, to €225 million, and that doesn't even count a recent major approval in asthma.
Dieter Weinand, Bayer’s head of the pharma division, will join Sanofi to lead a newly formed primary care unit, while Sanofi's Stefan Oelrich will take his post.
Sanofi and the Securities and Exchange Commission entered a $25 million civil settlement over bribery allegations in the Middle East.
Sanofi's CFO search lasted two months and led the company to a financial executive from French automaker PSA Group.